Skip to main content
polskiPL
European Commission logo print header

Next-generation biopharmaceutical downstream process

Cel

The scope of the project is the optimization of downstream process (DSP) for the production of Biopharmaceuticals. Biopharmaceuticals have been successfully used as efficient therapeutic drugs for many pathophysiological conditions since the first recombinant product, insulin, was approved in 1982. Despite its efficacy, accessibility is still limited due to extremely high costs. In the production chain, capturing and purifying still represents a major bottleneck. Consequently, improvements in this area produce substantial cost reductions and expand patients’ accessibility to highly efficient drugs. Another aim of this action is to cope with the changing manufacturing demands, by lowering its environmental footprint and moving to more sustainable technologies. This proposal’s main objective is to implement a fully integrated manufacturing platform based on continuous chromatography in combination with disposable techniques for all unit operations of the DSP sequence for biosimilar monoclonal antibodies and derivatives thereof. The action encompasses the entire DSP sequence. We will implement alternative technologies for primary separation, such as flocculation or tangential flow filtration. The expected outcome is a reduction in the size and number of downstream unit operations and the elimination of centrifugation. Alternative approaches to the batch process for the capture step, such as continuous chromatography, will be evaluated in order to improve the efficiency and lower the need for expensive resin volume. Additionally precipitation utilization will be evaluated as an approach to replace protein A chromatography as capture step. A disposable continuous chromatography system will be developed together with novel analytical tools and sensors. Since single-use disposable systems can substitute the extensive use of resources (water) and significantly reduce the overall utility needs, the whole DSP sequence will be carried out on disposable technology (PAT).

Dziedzina nauki

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

H2020-BIOTEC-2014-2015

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-LEIT-BIO-2014-1

System finansowania

IA - Innovation action

Koordynator

LEK FARMACEVTSKA DRUZBA DD
Wkład UE netto
€ 2 631 737,50
Adres
VEROVSKOVA ULICA 57
1526 LJUBLJANA
Słowenia

Zobacz na mapie
Region
Slovenija Zahodna Slovenija Osrednjeslovenska
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Linki
Koszt całkowity
€ 3 759 625,00

Uczestnicy (6)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 3 Września 2022

Moja broszura

Permalink: https://cordis.europa.eu/project/id/635557/pl

European Union, 2024